Evaluation to Assess Safety and Tolerability of DM199 in Subjects With Acute Ischemic Stroke

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This is a Phase II study to assess the safety and tolerability of DM199 in acute ischemic stroke patients. The study will be randomized, placebo controlled at multiple centers.
Epistemonikos ID: 19a8b7e7b10239c60d485b136e8d11871ae600cb
First added on: May 21, 2024